Anti-EED (embryonic ectoderm development, hEED, HEED, Polycomb protein EED, WAIT1, WAIT-1, WD protei

EED (Embryonic ectoderm development, also WAIT-1) is a 51kD member of the WD repeat ESC family of proteins. It is widely expressed, and constitutes part of both the PRC1 and PRC2 nuclear complexes. PRC1 contains EED, Suz12, RbAp46 and Ezh1 and is found in nonproliferating tissue. PRC2 differs only by the presence of Ezh2 and is found in proliferating tissues. Both complexes methylate histone H3 and act as gene repressors. Human EED is 441aa in length. It contains three phosphorylation sites (Ser34, Thr55, Thr57) followed by seven WD40 domains (aa91-441). There are two alternate start sites, one at Met15, and another that is 94aa upstream of the standard site, begins with a Val and generates a 69kD isoform. A third isoform variant shows an insertion of 25aa after Ser323, while a fourth variant shows a premature truncation after Lys400. Human and mouse EED are identical in amino acid sequence. Applications: Suitable for use in ELISA and Western Blot. Other applications not tested. Recommended Dilution: Western Blot: 1ug/ml, Direct ELISA: 0.5-1ug/ml. The detection limit for recombinant human EED is ~0.2ng/ml., Optimal dilutions to be determined by the researcher. Storage and Stability: Lyophilized and reconstituted products are stable for 12 months after receipt at -20°C. Reconstitute with sterile PBS. Aliquot to avoid repeated freezing and thawing. Store at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.